Aspercreme Is Falsely Advertised, Class Action Lawsuit Alleges
May 3, 2021 A class action alleges the maker of Aspercreme has misrepresented the lidocaine-based pain-reliever through “affirmative statements, half-truths, and omissions.”
Lawsuit Filings